secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001683168-25-007338
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma dismisses Bush & Associates, appoints M&K CPAS as auditor effective Sept 24, 2025
--------------------------------------------------------------------------------

- Dismissed Bush & Associates CPA LLC as independent auditor on Sept 24, 2025; no prior disagreements or reportable events.
- Retained M&K CPAS, PLLC as new independent registered public accounting firm effective same date.
- Audit reports for fiscal years 2023 and 2024 were unqualified; no adverse opinions or modifications.
- Company requested Bush & Associates to provide letter agreeing with disclosures; letter not yet received, will be filed by amendment.
- Change approved by board and audit committee; no consultations with M&K prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/0001683168-25-007338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer